OOIR: Observatory of International Research

Papers

(The H4-Index of Neuropsychopharmacology is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Pramipexole modulates fronto-subthalamic pathway in sequential working memory	756
Role of neuropeptide neuromedin U in the nucleus accumbens shell in cocaine self-administration in male rats	348
A new prism next to motherhood’s light: uncovering changes in neural function following childbirth	338
Fentanyl-induced hyperalgesia and analgesic tolerance in male rats: common underlying mechanisms and prevention by a polyamine deficient diet	191
ACNP 62nd Annual Meeting: Keyword Index	171
It’s about racism, not race: a call to purge oppressive practices from neuropsychiatry and scientific discovery	162
Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine	156
Inhibition of striatal indirect pathway during second postnatal week leads to long-lasting deficits in motivated behavior	149
The National Institute on Drug Abuse Summer Research Internship Program: Building a Diverse National Scientific Workforce	139
TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner	130
Using metabolic imaging to investigate neuromodulatory mechanisms of rTMS	130
Validation of a non-food or water motivated effort-based foraging task as a measure of motivational state in male mice	126
Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model	107
Targeted and transient opening of the blood brain barrier in discrete neurocircuits and brain regions	101
A sex-specific role for the bed nucleus of the stria terminalis in proactive defensive behavior	98
Delayed estrogen actions diminish food consumption without changing food approach, motor activity, or hypothalamic activation elicited by corticostriatal µ-opioid signaling	89
Distinct roles of excitatory and inhibitory neurons in the medial prefrontal cortex in the expression and reconsolidation of methamphetamine-associated memory in male mice	88
Potentiation of AMPA receptors for rapid therapeutic gain in psychiatry has reached a new level of excitement	88
Leveraging large-scale brain networks in rats to understand neurological and psychiatric disorders in humans	82
Is treatment-resistant schizophrenia a neuroimmune condition? Meta-analytic evidence from magnetic resonance spectroscopy	77
Gestational ethanol exposure impairs motor skills in female mice through dysregulated striatal dopamine and acetylcholine function	76
Sex differences in offspring risk and resilience following 11β-hydroxylase antagonism in a rodent model of maternal immune activation	75
ACNP 61st Annual Meeting: Poster Abstracts P541 – P809	71
Prefrontal allopregnanolone mediates the adverse effects of acute stress in a mouse model of tic pathophysiology	70
Parvalbumin interneuron mGlu5 receptors govern sex differences in prefrontal cortex physiology and binge drinking	67

Sex-specific nicotine sensitization and imprinting of self-administration in rats inform GWAS findings on human addiction phenotypes	67
Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect	66
Prefrontal-hippocampal interactions supporting the extinction of emotional memories: the retrieval stopping model	65
Leveraging ultra-high field (7T) MRI in psychiatric research	62
Hippocampus and amygdala fear memory engrams re-emerge after contextual fear relapse	62
Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study	61
A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of	59
Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders	56
Sensitive period-regulating genetic pathways and exposure to adversity shape risk for depression	56
Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes	56
Data-driven connectivity profiles relate to smoking cessation outcomes	55
Altered neuronal activity in the ventromedial prefrontal cortex drives nicotine intake escalation	54
Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis	53
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios	53
The GABAA receptor modulator zolpidem augments hippocampal-prefrontal coupling during non-REM sleep	53
Towards an understanding of psychedelic-induced neuroplasticity	52
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward	51
A path to novel, effective treatments for schizophrenia	51
Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial	51
IN MEMORIAM John Gary Csernansky 1954–2022	51
Effects of visual attention modulation on dynamic functional connectivity during own-face viewing in body dysmorphic disorder	50
The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer’s disease: a randomized, triple-blind, placebo-controlled trial	48
Chronic, combinatorial targeting of NMDARs and 5-HT4Rs exerts extended behavioral effects against stress-induced perseverative behavior and hyponeophagia	48
Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity	48